Robert J. Grun

Array ( [id] => 10600264 [patent_doc_number] => 09320812 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-04-26 [patent_title] => 'Modulators and methods of use' [patent_app_type] => utility [patent_app_number] => 13/992599 [patent_app_country] => US [patent_app_date] => 2011-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 81 [patent_no_of_words] => 56809 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13992599 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9223527 [patent_doc_number] => 20140018302 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-16 [patent_title] => 'Cancer Therapies and Diagnostics' [patent_app_type] => utility [patent_app_number] => 13/884709 [patent_app_country] => US [patent_app_date] => 2011-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 31969 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13884709 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8791659 [patent_doc_number] => 20130108628 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-02 [patent_title] => 'Method for treating cancer pain and/or rescuing analgesic effect of morphine treatment of cancer pain' [patent_app_type] => utility [patent_app_number] => 13/373018 [patent_app_country] => US [patent_app_date] => 2011-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 7823 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13373018 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10161455 [patent_doc_number] => 09192665 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-11-24 [patent_title] => 'Means and methods for treating DLBCL' [patent_app_type] => utility [patent_app_number] => 13/881889 [patent_app_country] => US [patent_app_date] => 2011-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19478 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 189 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13881889 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9462826 [patent_doc_number] => 20140127253 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-08 [patent_title] => 'BIODEGRADABLE PARTICULATE FORMULATIONS' [patent_app_type] => utility [patent_app_number] => 13/878561 [patent_app_country] => US [patent_app_date] => 2011-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 14533 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13878561 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11263288 [patent_doc_number] => 09487575 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-11-08 [patent_title] => 'Compositions and methods for treatment of gynecologic cancers' [patent_app_type] => utility [patent_app_number] => 13/877649 [patent_app_country] => US [patent_app_date] => 2011-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16900 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13877649 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11263288 [patent_doc_number] => 09487575 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-11-08 [patent_title] => 'Compositions and methods for treatment of gynecologic cancers' [patent_app_type] => utility [patent_app_number] => 13/877649 [patent_app_country] => US [patent_app_date] => 2011-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16900 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13877649 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9093740 [patent_doc_number] => 20130273051 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-17 [patent_title] => 'METHODS FOR THE DEVELOPMENT OF METZINCIN-SELECTIVE CATALYTIC CLEFT DIRECTED ANTIBODIES FOR THERAPEUTIC AND DIAGNOSTIC APPLICATIONS' [patent_app_type] => utility [patent_app_number] => 13/876966 [patent_app_country] => US [patent_app_date] => 2011-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14126 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13876966 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11658410 [patent_doc_number] => 09671404 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-06-06 [patent_title] => 'Use of myeloid cell biomarkers for the diagnosis of cancer' [patent_app_type] => utility [patent_app_number] => 13/239011 [patent_app_country] => US [patent_app_date] => 2011-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 2 [patent_no_of_words] => 8773 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 235 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13239011 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9698575 [patent_doc_number] => 20140248261 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-04 [patent_title] => 'ANTIBODY AGAINST MUTANT ALPHA-ACTININ-4' [patent_app_type] => utility [patent_app_number] => 14/343221 [patent_app_country] => US [patent_app_date] => 2011-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 15257 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14343221 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10136015 [patent_doc_number] => 09169327 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-10-27 [patent_title] => 'Targeting of podoplanin with lectin for use in the prevention and treatment of cancer' [patent_app_type] => utility [patent_app_number] => 13/218717 [patent_app_country] => US [patent_app_date] => 2011-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 3 [patent_no_of_words] => 9957 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13218717 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7658158 [patent_doc_number] => 20110307427 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-15 [patent_title] => 'Molecular markers predicting response to adjuvant therapy, or disease progression, in\nbreast cancer' [patent_app_type] => utility [patent_app_number] => 13/199068 [patent_app_country] => US [patent_app_date] => 2011-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5428 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0307/20110307427.pdf [firstpage_image] =>[orig_patent_app_number] => 13199068 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8302158 [patent_doc_number] => 20120184716 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-19 [patent_title] => 'Methods for the Generation of Multispecific and Multivalent Antibodies' [patent_app_type] => utility [patent_app_number] => 13/210723 [patent_app_country] => US [patent_app_date] => 2011-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 16498 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13210723 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7731624 [patent_doc_number] => 20120014984 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-19 [patent_title] => 'COMPOSITIONS AND METHODS FOR PREVENTION OF ESCAPE MUTATION IN THE TREATMENT OF HER2/NEU OVER-EXPRESSING TUMORS' [patent_app_type] => utility [patent_app_number] => 13/210696 [patent_app_country] => US [patent_app_date] => 2011-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 23934 [patent_no_of_claims] => 73 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20120014984.pdf [firstpage_image] =>[orig_patent_app_number] => 13210696 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10517032 [patent_doc_number] => 09244075 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-01-26 [patent_title] => 'Compositions and methods for detecting, diagnosing, and treating cancer' [patent_app_type] => utility [patent_app_number] => 13/813680 [patent_app_country] => US [patent_app_date] => 2011-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 42 [patent_no_of_words] => 45362 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13813680 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10083517 [patent_doc_number] => 09120856 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-01 [patent_title] => 'Anti-CD19 antibody having ADCC function with improved glycosylation profile' [patent_app_type] => utility [patent_app_number] => 13/811159 [patent_app_country] => US [patent_app_date] => 2011-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 38 [patent_no_of_words] => 20479 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13811159 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10103876 [patent_doc_number] => 09139650 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-22 [patent_title] => 'Fragment of humanized anti-EGFR antibody substituted-lysine variable fragment and use thereof' [patent_app_type] => utility [patent_app_number] => 13/816420 [patent_app_country] => US [patent_app_date] => 2011-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11419 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13816420 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8989734 [patent_doc_number] => 20130217015 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-22 [patent_title] => 'HMGA2 AS A BIOMARKER FOR DIAGNOSIS AND PROGNOSIS OF OVARIAN CANCER' [patent_app_type] => utility [patent_app_number] => 13/808813 [patent_app_country] => US [patent_app_date] => 2011-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9161 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13808813 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15634435 [patent_doc_number] => 10590195 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-03-17 [patent_title] => Homodimeric protein constructs [patent_app_type] => utility [patent_app_number] => 13/805709 [patent_app_country] => US [patent_app_date] => 2011-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 10541 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13805709 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15634435 [patent_doc_number] => 10590195 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-03-17 [patent_title] => Homodimeric protein constructs [patent_app_type] => utility [patent_app_number] => 13/805709 [patent_app_country] => US [patent_app_date] => 2011-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 10541 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13805709 [rel_patent_id] =>[rel_patent_doc_number] =>)